CI Medical Co Ltd
TSE:3540
Income Statement
Earnings Waterfall
CI Medical Co Ltd
Revenue
|
45.6B
JPY
|
Cost of Revenue
|
-33.6B
JPY
|
Gross Profit
|
12B
JPY
|
Operating Expenses
|
-9B
JPY
|
Operating Income
|
3B
JPY
|
Other Expenses
|
-907m
JPY
|
Net Income
|
2.1B
JPY
|
Income Statement
CI Medical Co Ltd
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||
Revenue |
24 324
N/A
|
24 892
+2%
|
25 807
+4%
|
26 486
+3%
|
26 899
+2%
|
28 876
+7%
|
28 763
0%
|
30 264
+5%
|
31 964
+6%
|
33 251
+4%
|
37 394
+12%
|
39 594
+6%
|
40 833
+3%
|
41 500
+2%
|
41 205
-1%
|
41 142
0%
|
41 754
+1%
|
42 073
+1%
|
42 891
+2%
|
43 473
+1%
|
44 125
+1%
|
45 071
+2%
|
45 628
+1%
|
|
Gross Profit | ||||||||||||||||||||||||
Cost of Revenue |
(17 870)
|
(18 280)
|
(18 947)
|
(19 377)
|
(19 690)
|
(21 192)
|
(21 010)
|
(21 961)
|
(22 979)
|
(23 506)
|
(26 100)
|
(27 475)
|
(28 495)
|
(29 273)
|
(29 600)
|
(29 640)
|
(30 093)
|
(30 394)
|
(31 218)
|
(32 058)
|
(32 558)
|
(33 253)
|
(33 633)
|
|
Gross Profit |
6 454
N/A
|
6 612
+2%
|
6 860
+4%
|
7 109
+4%
|
7 209
+1%
|
7 684
+7%
|
7 753
+1%
|
8 303
+7%
|
8 985
+8%
|
9 745
+8%
|
11 294
+16%
|
12 118
+7%
|
12 338
+2%
|
12 228
-1%
|
11 605
-5%
|
11 502
-1%
|
11 661
+1%
|
11 679
+0%
|
11 673
0%
|
11 415
-2%
|
11 567
+1%
|
11 818
+2%
|
11 995
+1%
|
|
Operating Income | ||||||||||||||||||||||||
Operating Expenses |
(4 523)
|
(4 866)
|
(4 944)
|
(5 220)
|
(5 376)
|
(5 473)
|
(5 653)
|
(5 958)
|
(6 092)
|
(6 261)
|
(6 591)
|
(6 624)
|
(6 874)
|
(7 041)
|
(7 082)
|
(7 271)
|
(7 359)
|
(7 535)
|
(7 683)
|
(7 933)
|
(8 134)
|
(8 454)
|
(9 006)
|
|
Selling, General & Administrative |
(4 523)
|
(4 758)
|
(4 922)
|
(5 111)
|
(5 267)
|
(5 473)
|
(5 637)
|
(5 958)
|
(6 092)
|
(6 261)
|
(6 572)
|
(6 623)
|
(6 873)
|
(7 041)
|
(7 062)
|
(7 242)
|
(7 358)
|
(7 533)
|
(7 667)
|
(7 931)
|
(8 132)
|
(8 452)
|
(8 977)
|
|
Research & Development |
0
|
0
|
(22)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(27)
|
|
Other Operating Expenses |
0
|
(109)
|
(0)
|
(109)
|
(109)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
0
|
(0)
|
(1)
|
(29)
|
(1)
|
0
|
(2)
|
(2)
|
(2)
|
0
|
(2)
|
|
Operating Income |
1 931
N/A
|
1 746
-10%
|
1 917
+10%
|
1 889
-1%
|
1 833
-3%
|
2 212
+21%
|
2 100
-5%
|
2 345
+12%
|
2 893
+23%
|
3 484
+20%
|
4 703
+35%
|
5 495
+17%
|
5 464
-1%
|
5 187
-5%
|
4 523
-13%
|
4 231
-6%
|
4 302
+2%
|
4 144
-4%
|
3 990
-4%
|
3 482
-13%
|
3 433
-1%
|
3 364
-2%
|
2 989
-11%
|
|
Pre-Tax Income | ||||||||||||||||||||||||
Interest Income Expense |
62
|
49
|
22
|
29
|
31
|
28
|
20
|
(18)
|
(69)
|
(77)
|
(73)
|
(27)
|
22
|
13
|
5
|
1
|
(22)
|
4
|
(3)
|
(70)
|
(72)
|
(67)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
(109)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(57)
|
(233)
|
(500)
|
(478)
|
(421)
|
(295)
|
0
|
(64)
|
(64)
|
(183)
|
48
|
165
|
159
|
113
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
31
|
34
|
35
|
29
|
27
|
21
|
21
|
36
|
38
|
40
|
54
|
61
|
68
|
65
|
52
|
39
|
29
|
41
|
47
|
(107)
|
(100)
|
(113)
|
84
|
|
Pre-Tax Income |
2 025
N/A
|
1 829
-10%
|
1 866
+2%
|
1 947
+4%
|
1 892
-3%
|
2 269
+20%
|
2 149
-5%
|
2 362
+10%
|
2 862
+21%
|
3 390
+18%
|
4 451
+31%
|
5 029
+13%
|
5 076
+1%
|
4 843
-5%
|
4 285
-12%
|
4 271
0%
|
4 245
-1%
|
4 125
-3%
|
3 851
-7%
|
3 353
-13%
|
3 426
+2%
|
3 343
-2%
|
3 184
-5%
|
|
Net Income | ||||||||||||||||||||||||
Tax Provision |
(566)
|
(472)
|
(536)
|
(532)
|
(546)
|
(696)
|
(644)
|
(755)
|
(938)
|
(1 126)
|
(1 530)
|
(1 720)
|
(1 740)
|
(1 660)
|
(1 464)
|
(1 454)
|
(1 447)
|
(1 416)
|
(1 326)
|
(1 181)
|
(1 201)
|
(1 166)
|
(1 084)
|
|
Income from Continuing Operations |
1 458
|
1 357
|
1 330
|
1 416
|
1 346
|
1 572
|
1 506
|
1 608
|
1 924
|
2 264
|
2 921
|
3 310
|
3 336
|
3 183
|
2 821
|
2 817
|
2 798
|
2 709
|
2 525
|
2 172
|
2 225
|
2 177
|
2 100
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
1
|
(4)
|
(12)
|
(16)
|
|
Net Income (Common) |
1 458
N/A
|
1 357
-7%
|
1 330
-2%
|
1 416
+6%
|
1 346
-5%
|
1 572
+17%
|
1 506
-4%
|
1 608
+7%
|
1 924
+20%
|
2 264
+18%
|
2 921
+29%
|
3 310
+13%
|
3 335
+1%
|
3 182
-5%
|
2 820
-11%
|
2 815
0%
|
2 798
-1%
|
2 709
-3%
|
2 521
-7%
|
2 173
-14%
|
2 219
+2%
|
2 162
-3%
|
2 082
-4%
|
|
EPS (Diluted) |
145.83
N/A
|
135.74
-7%
|
133
-2%
|
141.58
+6%
|
134.62
-5%
|
157.21
+17%
|
150.56
-4%
|
160.78
+7%
|
192.38
+20%
|
226.37
+18%
|
292.09
+29%
|
331.01
+13%
|
333.48
+1%
|
318.27
-5%
|
282
-11%
|
281.52
0%
|
279.82
-1%
|
270.92
-3%
|
252.13
-7%
|
217.32
-14%
|
221.92
+2%
|
216.22
-3%
|
208.22
-4%
|